Laurent Desire

USPTO Granted Patents = 6 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

5 out of 25

Exonhit Therapeutics, Sa

where one patent can have more than one assignee

Years Active: 2010-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9902710 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2018-02-27),

2. 9670181 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2017-06-06),

3. 9446044 - DYRK1 inhibitors and uses thereof (2016-09-20),

4. 9200016 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2015-12-01),

5. 7872015 - Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies (2011-01-18),

6. 7790864 - Antibody to BACE455, an alternative splice variant of the human beta-secretase (2010-09-07),

Title: Innovations of Laurent Desire

Introduction

Laurent Desire is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target phosphodiesterase 10 (PDE 10A). With a total of six patents to his name, his work has implications for treating various central nervous system diseases and metabolic disorders.

Latest Patents

One of his latest patents includes "Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)." This invention relates to compounds that are useful in treating conditions such as psychosis, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain, and ophthalmic diseases. Another patent with a similar focus is "Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)," which also addresses the same range of medical conditions.

Career Highlights

Throughout his career, Laurent has worked with prominent companies in the pharmaceutical industry, including Exonhit Therapeutics and Allergan, Inc. His experience in these organizations has allowed him to contribute to innovative research and development projects.

Collaborations

Laurent has collaborated with several professionals in his field, including Bertrand Leblond and Anne-Sophie Casagrande. These partnerships have enhanced his research efforts and broadened the impact of his inventions.

Conclusion

Laurent Desire's work exemplifies the intersection of innovation and healthcare, showcasing how targeted inventions can lead to advancements in medical treatments. His contributions continue to influence the pharmaceutical landscape significantly.

This text is generated by artificial intelligence and may not be accurate.